User profiles for Ally P.H. Prebtani
Ally PrebtaniProfessor Medicine, McMaster University Verified email at mcmaster.ca Cited by 3765 |
Hypertension Canada's 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children
…, P Lindsay, SW Rabkin, APH Prebtani… - Canadian Journal of …, 2020 - Elsevier
Hypertension Canada’s 2020 guidelines for the prevention, diagnosis, risk assessment, and
treatment of hypertension in adults and children provide comprehensive, evidence-based …
treatment of hypertension in adults and children provide comprehensive, evidence-based …
Hypertension Canada's 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children
…, KL Lavoie, RT Tsuyuki, G Honos, APH Prebtani… - Canadian Journal of …, 2018 - Elsevier
Hypertension Canada provides annually updated, evidence-based guidelines for the diagnosis,
assessment, prevention, and treatment of hypertension in adults and children. This year, …
assessment, prevention, and treatment of hypertension in adults and children. This year, …
[HTML][HTML] Primary aldosteronism: a common cause of resistant hypertension
• Patients who cannot be considered for adrenalectomy may consider an empiric trial of
spironolactone or eplerenone for blood pressure control.• If a normal or negative result for ARR …
spironolactone or eplerenone for blood pressure control.• If a normal or negative result for ARR …
[HTML][HTML] A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis …
AM Sawka, APH Prebtani, L Thabane, A Gafni… - BMC endocrine …, 2004 - Springer
Background Fractionated plasma metanephrine measurements are commonly used in
biochemical testing in search of pheochromocytoma. Methods We aimed to critically appraise the …
biochemical testing in search of pheochromocytoma. Methods We aimed to critically appraise the …
[PDF][PDF] Screening for type 1 and type 2 diabetes
…, Z Punthakee, T Ransom, APH Prebtani… - Canadian journal of …, 2013 - researchgate.net
Testing with a 2-hour plasma glucose (2hPG) in a 75 g oral glucose tolerance test (OGTT)
should be undertaken in individuals with an FPG of 6.1 e6. 9 mmol/L and/or an A1C of 6.0% e6…
should be undertaken in individuals with an FPG of 6.1 e6. 9 mmol/L and/or an A1C of 6.0% e6…
Reducing the risk of developing diabetes
Ideal prevention strategies for both type 1 and type 2 diabetes should range from efforts
focused on individuals identified as being at risk for developing diabetes to broader group-and …
focused on individuals identified as being at risk for developing diabetes to broader group-and …
Treatment of hypertension
Observational and randomized clinical trials and observational data show a strong association
between raised systolic and diastolic blood pressures (BPs) and clinically important …
between raised systolic and diastolic blood pressures (BPs) and clinically important …
Reducing the risk of developing diabetes
…, R Goldenberg, A Mikalachki, APH Prebtani… - Canadian Journal of …, 2013 - Elsevier
Ideal preventive strategies for both type 1 and type 2 diabetes should range from focusing
efforts on individuals identified as being at risk for developing diabetes to broader, more group-…
efforts on individuals identified as being at risk for developing diabetes to broader, more group-…
Worrisome striae
APH Prebtani, D Donat, S Ezzat - The Lancet, 2000 - thelancet.com
A 29-year-old pregnant woman gravida four para three at 29 weeks of gestation was admitted
in July, 1999, because of difficult to control hypertension and hyperglycaemia since mid-…
in July, 1999, because of difficult to control hypertension and hyperglycaemia since mid-…
[HTML][HTML] Pantoprazole-induced acute interstitial nephritis
Discussion Pantoprazole-induced acute interstitial nephritis is an increasingly known
complication of proton pump inhibitor therapy. In our patient’s case, confounding factors delayed …
complication of proton pump inhibitor therapy. In our patient’s case, confounding factors delayed …